Modulation of gene expression by Pseudomonas aeruginosa during chronic infection in the adult cystic fibrosis lung

Microbiology (United Kingdom)

Volumn 159, Issue PART11, 2013, Pages 2354-2363

  Harmer, Christopher ^a   Alnassafi, Khaled ^a   Hu, Honghuah ^a   Elkins, Mark ^b   Bye, Peter ^b   Rose, Barbara ^a   Cordwell, Stuart ^a   Triccas, James A ^a   Harbour, Colin ^a   Manos, Jim ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRULENCE FACTOR;

ADULT; ARTICLE; ASSAY; BACTERIAL VIRULENCE; CAENORHABDITIS ELEGANS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; EPIDEMIC; FIMBRIA; FREQUENT CLONAL COMPLEX; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOMIC ISLAND; HUMAN; IN VITRO STUDY; INFREQUENT CLONAL COMPLEX; LUNG INFECTION; MICROARRAY ANALYSIS; MICROBIOLOGICAL PARAMETERS; MODULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; TYPE III SECRETION SYSTEM;

ADULT; ANIMALS; CAENORHABDITIS ELEGANS; CYSTIC FIBROSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; LUNG; MICROARRAY ANALYSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEQUENCE DELETION; SURVIVAL ANALYSIS; VIRULENCE; VIRULENCE FACTORS;

EID: 84886663108     PISSN: 13500872     EISSN: 14652080     Source Type: Journal    
DOI: 10.1099/mic.0.066985-0     Document Type: Article

References (51)

1. Al-Aloul, M., Crawley, J., Winstanley, C., Hart, C. A., Ledson, M. J. & Walshaw, M. J. (2004). Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 59, 334-336.
2. Armstrong, D., Bell, S., Robinson, M., Bye, P., Rose, B., Harbour, C., Lee, C., Service, H., Nissen, M. & other authors (2003). Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. J Clin Microbiol 41, 2266-2267.
3. Carter, M. E., Fothergill, J. L., Walshaw, M. J., Rajakumar, K., Kadioglu, A. & Winstanley, C. (2010). A subtype of a Pseudomonas aeruginosa cystic fibrosis epidemic strain exhibits enhanced virulence in a murine model of acute respiratory infection. J Infect Dis 202, 935-942.
4. Casadevall, A. & Pirofski, L. A. (2009). Virulence factors and their mechanisms of action: the view from a damage-response framework. J Water Health 7 (Suppl. 1), S2-S18.
5. Chemani, C., Imberty, A., de Bentzmann, S., Pierre, M., Wimmerová, M., Guery, B. P. & Faure, K. (2009). Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands. Infect Immun 77, 2065-2075.
6. Ciofu, O., Mandsberg, L. F., Wang, H. & Høiby, N. (2012). Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections. FEMS Immunol Med Microbiol 65, 215-225.
7. Costerton, J. W., Stewart, P. S. & Greenberg, E. P. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322.
8. Eberl, L. & Tümmler, B. (2004). Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis: genome evolution, interactions and adaptation. Int J Med Microbiol 294, 123-131.
9. Feinbaum, R. L., Urbach, J. M., Liberati, N. T., Djonovic, S., Adonizio, A., Carvunis, A. R. & Ausubel, F. M. (2012). Genome-wide identification of Pseudomonas aeruginosa virulence-related genes using a Caenorhabditis elegans infection model. PLoS Pathog 8, e1002813.
10. Fick, R. B., Jr, Sonoda, F. & Hornick, D. B. (1992). Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway. Semin Respir Infect 7, 168-178.
11. Fung, C., Naughton, S., Turnbull, L., Tingpej, P., Rose, B., Arthur, J., Hu, H., Harmer, C., Harbour, C. & other authors (2010). Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum. J Med Microbiol 59, 1089-1100.
12. Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. (2004). affy-Analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307-315.
13. Govan, J. R. & Deretic, V. (1996). Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60, 539-574.
14. Govan, J. R., Doherty, C. J., Nelson, J. W., Brown, P. H., Greening, A. P., Maddison, J., Dodd, M. & Webb, A. K. (1993). Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342, 15-19.
15. Hare, N. J., Solis, N., Harmer, C., Marzook, N. B., Rose, B., Harbour, C., Crossett, B., Manos, J. & Cordwell, S. J. (2012). Proteomic profiling of Pseudomonas aeruginosa AES-1R, PAO1 and PA14 reveals potential virulence determinants associated with a transmissible cystic fibrosis-associated strain. BMC Microbiol 12, 16.
16. Harmer, C. J., Triccas, J. A., Hu, H., Rose, B., Bye, P., Elkins, M. & Manos, J. (2012). Pseudomonas aeruginosa strains from the chronically infected cystic fibrosis lung display increased invasiveness of A549 epithelial cells over time. Microb Pathog 53, 37-43.
17. Heydorn, A., Ersbøll, B., Kato, J., Hentzer, M., Parsek, M. R., Tolker-Nielsen, T., Givskov, M. & Molin, S. (2002). Statistical analysis of Pseudomonas aeruginosa biofilm development: impact of mutations in genes involved in twitching motility, cell-to-cell signaling, and stationary-phase sigma factor expression. Appl Environ Microbiol 68, 2008-2017.
18. Hocquet, D., Bertrand, X., Köhler, T., Talon, D. & Plésiat, P. (2003). Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone. Antimicrob Agents Chemother 47, 1887-1894.
19. Hogardt, M. & Heesemann, J. (2010). Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int J Med Microbiol 300, 557-562.
20. Hogardt, M. & Heesemann, J. (2013). Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung. Curr Top Microbiol Immunol 358, 91-118.
21. Høiby, N., Frederiksen, B. & Pressler, T. (2005). Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 4 (Suppl. 2), 49-54.
22. Høiby, N., Ciofu, O., Johansen, H. K., Song, Z. J., Moser, C., Jensen, P. O., Molin, S., Givskov, M., Tolker-Nielsen, T. & Bjarnsholt, T. (2011). The clinical impact of bacterial biofilms. Int J Oral Sci 3, 55-65.
23. Jones, A. K., Fulcher, N. B., Balzer, G. J., Urbanowski, M. L., Pritchett, C. L., Schurr, M. J., Yahr, T. L. & Wolfgang, M. C. (2010). Activation of the Pseudomonas aeruginosa AlgU regulon through mucA mutation inhibits cyclic AMP/Vfr signaling. J Bacteriol 192, 5709-5717.
24. Kosorok, M. R., Zeng, L., West, S. E., Rock, M. J., Splaingard, M. L., Laxova, A., Green, C. G., Collins, J. & Farrell, P. M. (2001). Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 32, 277-287.
25. Kurz, C. L. & Ewbank, J. J. (2000). Caenorhabditis elegans for the study of host-pathogen interactions. Trends Microbiol 8, 142-144.
26. Landry, R. M., An, D., Hupp, J. T., Singh, P. K. & Parsek, M. R. (2006). Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance. Mol Microbiol 59, 142-151.
27. Liang, X., Pham, X. Q., Olson, M. V. & Lory, S. (2001). Identification of a genomic island present in the majority of pathogenic isolates of Pseudomonas aeruginosa. J Bacteriol 183, 843-853.
28. Luján, A. M., Maciá, M. D., Yang, L., Molin, S., Oliver, A. & Smania, A. M. (2011). Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators. PLoS ONE 6, e27842.
29. Manos, J., Arthur, J., Rose, B., Tingpej, P., Fung, C., Curtis, M., Webb, J. S., Hu, H., Kjelleberg, S. & other authors (2008). Transcriptome analyses and biofilm-forming characteristics of a clonal Pseudomonas aeruginosa from the cystic fibrosis lung. J Med Microbiol 57, 1454-1465.
30. Manos, J., Arthur, J., Rose, B., Bell, S., Tingpej, P., Hu, H., Webb, J., Kjelleberg, S., Gorrell, M. D. & other authors (2009). Gene expression characteristics of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa during biofilm and planktonic growth. FEMS Microbiol Lett 292, 107-114.
31. Naughton, S., Parker, D., Seemann, T., Thomas, T., Turnbull, L., Rose, B., Bye, P., Cordwell, S., Whitchurch, C. & Manos, J. (2011). Pseudomonas aeruginosa AES-1 exhibits increased virulence gene expression during chronic infection of cystic fibrosis lung. PLoS ONE 6, e24526.
32. Nixon, G. M., Armstrong, D. S., Carzino, R., Carlin, J. B., Olinsky, A., Robertson, C. F. & Grimwood, K. (2001). Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 138, 699-704.
33. Palmer, K. L., Mashburn, L. M., Singh, P. K. & Whiteley, M. (2005). Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 187, 5267-5277.
34. Rampioni, G., Schuster, M., Greenberg, E. P., Zennaro, E. & Leoni, L. (2009). Contribution of the RsaL global regulator to Pseudomonas aeruginosa virulence and biofilm formation. FEMS Microbiol Lett 301, 210-217.
35. Rao, J., Damron, F. H., Basler, M., Digiandomenico, A., Sherman, N. E., Fox, J. W., Mekalanos, J. J. & Goldberg, J. B. (2011). Comparisons of two proteomic analyses of non-mucoid and mucoid Pseudomonas aeruginosa clinical isolates from a cystic fibrosis patient. Front Microbiol 2, 162.
36. Salunkhe, P., Smart, C. H., Morgan, J. A., Panagea, S., Walshaw, M. J., Hart, C. A., Geffers, R., Tümmler, B. & Winstanley, C. (2005). A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J Bacteriol 187, 4908-4920.
37. Schuster, M., Lostroh, C. P., Ogi, T. & Greenberg, E. P. (2003). Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J Bacteriol 185, 2066-2079.
38. Sifri, C. D., Baresch-Bernal, A., Calderwood, S. B. & von Eiff, C. (2006). Virulence of Staphylococcus aureus small colony variants in the Caenorhabditis elegans infection model. Infect Immun 74, 1091-1096.
39. Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D'Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P. & other authors (2006). Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103, 8487-8492.
40. Sonawane, A., Jyot, J. & Ramphal, R. (2006). Pseudomonas aeruginosa LecB is involved in pilus biogenesis and protease IV activity but not in adhesion to respiratory mucins. Infect Immun 74, 7035-7039.
41. Sriramulu, D. D., Lünsdorf, H., Lam, J. S. & Römling, U. (2005). Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J Med Microbiol 54, 667-676.
42. Stenbit, A. E. & Flume, P. A. (2011). Pulmonary exacerbations in cystic fibrosis. Curr Opin Pulm Med 17, 442-447.
43. Tan, M. W., Rahme, L. G., Sternberg, J. A., Tompkins, R. G. & Ausubel, F. M. (1999). Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc Natl Acad Sci U S A 96, 2408-2413.
44. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D.H. & Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J ClinMicrobiol 33, 2233-2239.
45. Tingpej, P., Smith, L., Rose, B., Zhu, H., Conibear, T., Al Nassafi, K., Manos, J., Elkins, M., Bye, P. & other authors (2007). Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. J Clin Microbiol 45, 1697-1704.
46. Tingpej, P., Elkins, M., Rose, B., Hu, H., Moriarty, C., Manos, J., Barras, B., Bye, P. & Harbour, C. (2010). Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa. Respirology 15, 923-929.
47. Wagner, V. E., Bushnell, D., Passador, L., Brooks, A. I. & Iglewski, B. H. (2003). Microarray analysis of Pseudomonas aeruginosa quorumsensing regulons: effects of growth phase and environment. J Bacteriol 185, 2080-2095.
48. Waite, R. D., Papakonstantinopoulou, A., Littler, E. & Curtis, M. A. (2005). Transcriptome analysis of Pseudomonas aeruginosa growth: comparison of gene expression in planktonic cultures and developing and mature biofilms. J Bacteriol 187, 6571-6576.
49. Whiteley, M., Bangera, M. G., Bumgarner, R. E., Parsek, M. R., Teitzel, G. M., Lory, S. & Greenberg, E. P. (2001). Gene expression in Pseudomonas aeruginosa biofilms. Nature 413, 860-864.
50. Winsor, G. L., Lam, D. K., Fleming, L., Lo, R., Whiteside, M. D., Yu, N. Y., Hancock, R. E. & Brinkman, F. S. (2011). Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res 39 (Database issue), D596-D600.
51. Winstanley, C., Langille, M.G., Fothergill, J. L., Kukavica-Ibrulj, I., Paradis-Bleau, C., Sanschagrin, F., Thomson, N. R., Winsor, G. L., Quail, M. A. & other authors (2009). Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res 19, 12-23.